Company / FCF Margin
ABEONA THERAPEUTICS INC. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-1448.5%
FY2025
5-year range
-3084.4% / -363.6%
FY2021-FY2025
Trend
-35.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 10 years, ranging from -3084.4% in FY2023 to -363.6% in FY2021.
Based on SEC 10-K filings.
-1448.5% in FY2025 with a 5-year CAGR of -757.2%.
Improved from -3084.4% to -1448.5% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +878.7pp
- 5-Year Change
- -757.2pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin decreased 35.8% year-over-year.
- Peak fcf margin was recorded in FY2021.
- Lowest fcf margin in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1448.5% | -35.8% |
| FY2024 | -1066.9% | +65.4% |
| FY2023 | -3084.4% | -32.5% |
| FY2022 | -2327.2% | -540.1% |
| FY2021 | -363.6% | +47.4% |
| FY2020 | -691.3% | +75.4% |
| FY2019 | -2809.4% | -74.2% |
| FY2018 | -1612.9% | +42.6% |
| FY2017 | -2809.4% | -172.3% |
| FY2016 | -1031.8% | -492.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026